Cell and gene therapy represent a new human health paradigm, with the potential to provide curative solutions rather than just chronic treatments for a variety of human diseases and genetic disorders. Rapid growth in the cell therapy industry is driving demand for cellular manufacturing, a process that can make or break the commercial success of a clinically promising cellular therapeutic.
Over the past several years at Nelsen Biomedical, we have gained exclusive insights from biomanufacturing experts regarding key factors that influence manufacturing decisions, elements essential to the success of current leaders in cell production, and competitive intelligence on large and small scale automated manufacturing systems.
We share these insights in our new Manufacturing Matters in Cell Therapy market report. In addition, we analyze market trends in the cell therapy industry, revealing near-term opportunities for cell therapy companies, as well as market entrance and adoption strategies for providers of products and services for cell manufacturing. For more information, see the table of contents and our brief version.